menu
    • menu

    Company profile for Salubris Biotherapeutics

    NEW Drugs in Dev: 3
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At SalubrisBio, our mission is to develop first-in-class biologics that improve the health and quality of life for people living with complicated diseases. We have the passion, commitment, and expertise needed to drive our assets through all phases of clinical development to deliver novel biologic therapies to patients. SalubrisBio is the first company in the world to bring a bispecific antibody into clinical trials in a ca...
    At SalubrisBio, our mission is to develop first-in-class biologics that improve the health and quality of life for people living with complicated diseases. We have the passion, commitment, and expertise needed to drive our assets through all phases of clinical development to deliver novel biologic therapies to patients. SalubrisBio is the first company in the world to bring a bispecific antibody into clinical trials in a cardiovascular indication. We endeavor to make this the first of many global innovation achievements.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Salubris BiotherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    45 West Watkins Mill Road, Suite E, Gaithersburg, MD 20878
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.salubrisbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Salubris Biotherapeutics Announces Dose Escalation Data for JK06
    Salubris Biotherapeutics Announces Dose Escalation Data for JK06

    18 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-18/salubris-biotherapeutics-announces-dose-escalation-data-for-jk06-a-5t4-targeted-antibody-drug-conju

    PHARMIWEB
    18 Oct 2025
    Share Share
    Salubris Biotherapeutics Updates Jk07 & Jk06 Clinical Programs
    Salubris Biotherapeutics Updates Jk07 & Jk06 Clinical Programs

    29 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250929916425/en/Salubris-Biotherapeutics-Provides-Updates-on-JK07-and-JK06-Clinical-Programs

    BUSINESSWIRE
    29 Sep 2025
    Share Share
    Salubris Announces Positive Data in JK07 Heart Failure Trial
    Salubris Announces Positive Data in JK07 Heart Failure Trial

    22 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250122643894/en

    BUSINESSWIRE
    22 Jan 2025
    Share Share
    Salubris Biotherapeutics' JK06 ADC Trial Approved By European Regulator
    Salubris Biotherapeutics' JK06 ADC Trial Approved By European Regulator

    05 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240801499825/en

    BUSINESSWIRE
    05 Aug 2024
    Share Share
    Salubris Announces $35M Financing, Pipeline Update
    Salubris Announces $35M Financing, Pipeline Update

    22 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240422669702/en

    BUSINESSWIRE
    22 Apr 2024
    Share Share
    Salubris Presents Positive Initial Data from Phase 1b/2 Clinical Trial of JK08
    Salubris Presents Positive Initial Data from Phase 1b/2 Clinical Trial of JK08

    23 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231023733843/en

    BUSINESSWIRE
    23 Oct 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search